Foley Hoag: New Jersey Cannabis – Right Place, Right Time
Authored By: Foley Hoag New Jersey Cannabis had itself a week. Following a recent decision permitting the New Jersey Department of Health, Medical Marijuana Division (“DOH”) to continue scoring its 2019 Request for Applications (“2019 RFA”) and award twenty-four (24)...
Greenbaum Rowe Smith & Davis LLP: New Law And Attorney General Directive Serve To Vacate Prior NJ State Court Marijuana Possession Verdicts, Pleas, And Diversionary Programs
Authored By Published Via JD Supra New Law And Attorney General Directive Serve To Vacate Prior NJ State Court Marijuana Possession Verdicts, Pleas, And Diversionary Programs On February 22, 2021, New Jersey Governor Phil Murphy signed into law sweeping...
Jenner & Block: Overview of Environmental Health and Safety Compliance Issues Facing the Cannabis Industry
Authored By: Jenner & Block LLP As more states legalize the use of cannabis[1], the market value of the U.S. cannabis industry is projected to reach $30 billion annually by 2025. Fifteen states currently allow the recreational use of cannabis and 36 states...
Michael Sassano: GMP & Compliance: GMP SERIES #1: “Starting Your GMP Approval Process for Cannabis Correctly”
Authored By : Michael Sassano Thankyou to our newest contributor Michael Sassano who will be penning a series of articles for us explaining GMP compliance. If you are a North American company wishing to do business in the EU, UK , Australia & NZ you will need to...
Judge Mary A. Celeste (ret.): Has the Marijuana Classification Under the Controlled Substances Act Outlived Its Definition?
Authors Melia Thompson-Dudiak† Introduction Under the Control Substances Act (“CSA”), marijuana is currently scheduled as an “I” drug.[1] In a classification of “V” schedules, “I” is considered the most dangerous because it is deemed to have a “high...Top 200 Cannabis Lawyers
We Support